Deletion hotspot in the argininosuccinate lyase gene:: Association with topoisomerase II and DNA polymerase α sites

被引:6
作者
Christodoulou, John
Craig, Hugh J.
Walker, David C.
Weaving, Linda S.
Pearson, Christopher E.
McInnes, Roderick R.
机构
[1] Univ Toronto, Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Pediat & Mol & Med Genet, Toronto, ON M5G 1X8, Canada
关键词
CFTR; ESE; ASL; argininosuccinate lyase; urea cycle; deletion hotspot; slipped mispairing;
D O I
10.1002/humu.20352
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Molecular analysis of argininosuccinate lyase (ASAL) deficiency has led to the identification of a deletion hotspot in the ASL gene. Six individuals with ASAL deficiency had alleles that led to a complete absence of exon 13 from the ASL mRNA; each had a partial deletion of exon 13 in the genomic DNA. In all six patients, the deletions begin 18 bp upstream of the 3' end of exon 13. In four cases, the deletions were 13 bp in length, and ended within exon 13, whereas in two other patients the deletions were 25 bp and extended into intron 13. The sequence at which these deletions begin overlaps both a putative topoisomerase 11 recognition site and a DNA polymerase alpha mutation/frameshift site. Moreover, the topoisomerase 11 cut site is situated precisely at the beginning of the deletions, which are flanked by small (2- and 3-bp) direct repeats. We note that a similar concurrence of these two putative enzyme sites can be found in a number of other deletion sites in the human genome, most notably the Delta F508 deletion in the CFTR gene. These findings suggest that the joint presence of these two enzyme sites represents a DNA sequence context that may favor the occurrence of small deletions. Hum Mutat 27(11), 1065-1071, 2006. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:1065 / 1071
页数:7
相关论文
共 39 条
[1]
Disease-causing mutations in the human genome [J].
Antonarakis, SE ;
Krawczak, M ;
Cooper, DN .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (Suppl 3) :S173-S178
[2]
Effect of the DNA topoisomerase II inhibitor VP-16 on illegitimate recombination in yeast chromosomes [J].
Asami, Y ;
Jia, DW ;
Tatebayashi, K ;
Yamagata, K ;
Tanokura, M ;
Ikeda, H .
GENE, 2002, 291 (1-2) :251-257
[3]
ILLEGITIMATE RECOMBINATION MEDIATED BY CALF THYMUS DNA TOPOISOMERASE-II INVITRO [J].
BAE, YS ;
KAWASAKI, I ;
IKEDA, H ;
LIU, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) :2076-2080
[4]
BAE YS, 1991, GENE, V101, P285
[5]
BARBOSA P, 1991, J BIOL CHEM, V266, P5286
[7]
Brusilow S., 2001, The Metabolic Molecular Bases of Inherited Disease, V8th ed., P1909
[8]
ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[9]
CHIBA M, 1989, J BIOL CHEM, V264, P12785
[10]
PREVENTION OF PRE-PCR MIS-PRIMING AND PRIMER DIMERIZATION IMPROVES LOW-COPY-NUMBER AMPLIFICATIONS [J].
CHOU, Q ;
RUSSELL, M ;
BIRCH, DE ;
RAYMOND, J ;
BLOCH, W .
NUCLEIC ACIDS RESEARCH, 1992, 20 (07) :1717-1723